Isolation and diagnosis of Clostridium perfringens from lobbies and surgical theaters of hospitals and Showing their Sensitivity to antibiotics
Abstract
The study included taking 100 samples from different sources, including the hospital environment samples (lobbies and operating theaters) , in Al-Khader General Hospital and in the city of lraq for the period from October 2021 to April 2022 . The results of isolation and diagnosis showed the growth of 27 isolates that are positive for Clostridium perfringens, distributed between 18 isolates (25.7%) from pollution of different lobby hospital, 9 isolates (30.0%) from different operating theaters, Microscopical, cultural, and biochemical examinations were used to diagnose these isolates in addition to the Api 20A method. A variety of antibiotic kinds were examined to see how sensitive the isolates were, and All bacterial١٢isolates tested positive for hight sensitivity to imipenem when the isolates' resistance to various antibiotics was assessed. Streptomycin sensitivity was (96.66%), Ampicillin sensitivity was (13.3%), and Erythromycin sensitivity was (86.66%), while metronidazole resistance was 100% in all isolates.
Downloads
References
[2[-Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis. 2008;8:101–13.
[3[- Lugauska A. and Krikstaponis A. (2004) Filamentous fungi isolated in hospitals and some medical institutions in Lithuania .Indoor Built Environment. 13:101-113
[4]- Jain A, Venkatesh V, Agarwal J. Microbiology Practical Manual E-Book: 1st ed. Elsevier .India. 2018
[5]-Grass JE, Gould LH, Mahon BE. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998–2010. Foodborne pathogens and disease. 2013 Feb 1;10(2):131-136.
[6]-McDonel J.L. Toxins of Clostridium perfringens types A, B, C, D, and E.In Dorner F, Drews H (ed), Pharmacology of bacterial toxins. Pergamon Press, Oxford, England. 1986;477–517.
[7]- Petit L, Gibert M, Popoff MR. Clostridium perfringens: toxinotype and genotype. Trends in microbiology. 1999 Mar 1;7(3):104-110.
[8]- Huang, I. H., Raju, D., Paredes-Sabja, D., and Sarker, M.R. 2007. Clostridium perfringens: Sporulation, Spore Resistance and Germination. Bang. J. Microbiol. 24:1-8
[9] Ali MR, Mohamed Ali SS, Abdulrazzak AA. Isolation and Diagnosis of Clostridium perfringens from Clinical Samples and the Environments of some Baghdad Hospital and Detection of their Virulence Factors. Al-Mustansiriyah Journal of Science. 2011;4(22):37–55.
]10]-Brooks, G.F.; Butel, J.S. and Mores, S.A. Jawetz Melnick and Adel Berg's, Medical Microbiology. 22 editions, Lange Medical Books/McGraw Hill. U.S.A. (2001).
[11]-Atlas, R.M.; Parks, L.C. and Brown, A.E. laboratory Manual of Experimental Microbiology. Mosby company .Missouri. U.S.A. (1995).
[12]- Cappuccino JG, Welsh CT. Microbiology: A Laboratory Manual, Global edition. 11th ed. Pearson Education Limited. 2017.
[13]- CLSI (Clinical and Laboratory Standards Institute). Methods for antimicrobial susceptibility testing of bacteria. Setting the standard for quality in medical laboratory testing around the world. M100,28th ed. 2018.
[14] - Kelly CM, Heidir S, Cowan MK, Smith H. Microbiology, 5th ed. Aystems Approach, McGraw-Hill, USA. 2018
[15]- Tille PM. Baily and scott’s Diagnostic Microbiology- E- Book . 14th ed . St. Louis, Missouri : Elsevier. China. 2017.
[16]-Mahon CR, Lehman DC, Manuselis G. Textbook of Diagnostic Microbiology.5th ed. Saunders, Elsevier.Inc, China. 2015
[17]-Abdullatef, Fallah H., Bassim M. Al-khafaji, Anwar H. Jawad, and Qassim J. Talib. "The Bacterial Contamination of the Operating lounges in Hospitals of Al-Diwaniyah Province with the Two types of Intestinal E. coli and St. aureus Cutaneous." Al-Qadisiyah Journal Of Pure Science 26, no. 1 (2021): 1-9.
[18]-Skidmore-Roth, L. (2017). Mosby's Drug Guide for Nursing Students with 2018 Update - E-Book.12th ed. Elsevier.USA.
[19]- Land KM, Johnson PJ. Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resistance Updates. 1999 Oct 1;2(5):289-294.
[20]- Howland RD, Mycek MJ. pharmacology . 3th ed. Lipincott Williams and Wilkins . USA. 2006; pp:77–79.
Author(s) and co-author(s) jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere. Author(s) agree to the terms that the GPH Journal will have the full right to remove the published article on any misconduct found in the published article.
